United States of America v. Ahmad Khawaja

471 F. Supp. 3d 426, 2020 DNH 063
CourtDistrict Court, D. New Hampshire
DecidedApril 22, 2020
Docket18-cr-127-LM
StatusPublished

This text of 471 F. Supp. 3d 426 (United States of America v. Ahmad Khawaja) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States of America v. Ahmad Khawaja, 471 F. Supp. 3d 426, 2020 DNH 063 (D.N.H. 2020).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW HAMPSHIRE

United States of America

v. Criminal No. 18-cr-127-LM Opinion No. 2020 DNH 063 Ahmad Khawaja

O R D E R

On May 2, 2019, defendant pleaded guilty to one count of

importation of a controlled substance (MDMA) in violation of 21

U.S.C. §§ 952(a), 960(a)(1), and 960(b)(3). On January 3, 2020,

the court sentenced defendant to 30 months of imprisonment and

recommended that he participate in the Residential Drug Abuse

Program while incarcerated. On February 20, 2020, defendant

self-surrendered to the Federal Correctional Institution Danbury

in Connecticut where he remains incarcerated. In light of the

spread of COVID-19 in federal prisons and his respiratory health

issues, defendant requests pursuant to 18 U.S.C. § 3582(c)(1)(A)

that the court allow him to serve the remainder of his sentence

in home confinement. Doc. no. 43. The government objects. For

the following reasons, the court denies defendant’s motion.

STANDARD OF REVIEW

A court may grant so-called “compassionate release” to a

defendant under 18 U.S.C. § 3582(c)(1)(A). 18 U.S.C. §

3582(c)(1)(A) provides, in relevant part, that: the court, upon motion of the Director of the Bureau of Prisons or upon motion of the defendant after the defendant has fully exhausted all administrative rights to appeal a failure of the Bureau of Prisons to bring a motion on the defendant’s behalf or the lapse of 30 days from the receipt of such a request by the warden of the defendant's facility, whichever is earlier, may reduce the term of imprisonment (and may impose a term of probation or supervised release with or without conditions that does not exceed the unserved portion of the original term of imprisonment), after considering the factors set forth in section 3553(a) to the extent that they are applicable, if it finds that—

(i) extraordinary and compelling reasons warrant such a reduction

. . .

and that such a reduction is consistent with applicable policy statements issued by the Sentencing Commission.

18 U.S.C. § 3582(c)(1)(A); see also U.S.S.G. § 1B1.13

(sentencing guidelines policy statement on compassionate

release). Under this statute, a district court may properly

consider a motion for compassionate release under three

circumstances: (1) the motion is filed by the Director of the

Bureau of Prisons (“BOP”); (2) the motion is filed by defendant

after he exhausts all his administrative rights to appeal BOP’s

refusal to bring a motion on his behalf; or (3) the motion is

filed by defendant 30 days after defendant requested BOP to

petition for compassionate release on his behalf. 18 U.S.C. §

3582(c)(1)(A).

2 Once a motion for compassionate release is properly before

the court, the court must then determine if defendant is

eligible for release. The statutory language quoted above

requires that defendant show that “extraordinary and compelling

reasons warrant” a reduction in his sentence, that the court

consider the factors set forth in 18 U.S.C. § 3553(a) to the

extent applicable, and that the reduction be “consistent” with

the Sentencing Commission’s applicable policy statements. 18

U.S.C. § 3582(c)(1)(A). The Sentencing Commission’s policy

statement regarding compassionate release adds the requirement

that the court find that “[t]he defendant is not a danger to the

safety of any other person or to the community, as provided in

18 U.S.C. § 3142(g).” U.S.S.G. § 1B1.13(2).

In short, a court may reduce a term of imprisonment under

the compassionate release provision if it: (1) finds that

extraordinary and compelling reasons warrant the reduction; (2)

finds that the defendant will not be a danger to the safety of

any other person or the community; and (3) the sentencing

factors outlined in 18 U.S.C. § 3553(a) weigh in favor of

reduction. See 18 U.S.C. § 3582(c)(1)(A); U.S.S.G. § 1B1.13;

see also United States v. Sapp, No. 14-CR-20520, 2020 WL 515935,

at *2 (E.D. Mich. Jan. 31, 2020); United States v. Willis, 382

F. Supp. 3d 1185, 1187 (D.N.M. 2019). The defendant has the

3 burden of showing that he or she is entitled to a sentence

reduction. United States v. Ebbers, No. S402CR11443VEC, 2020 WL

91399, at *4 (S.D.N.Y. Jan. 8, 2020). The court has “broad

discretion in deciding whether to grant or deny a motion for

sentence reduction.” United States v. Paul Gileno, No. 3:19-CR-

161-(VAB)-1, 2020 WL 1307108, at *2 (D. Conn. Mar. 19, 2020)

(internal quotation marks omitted).

BACKGROUND

On February 20, 2020, defendant began serving his 30-month

sentence at FCI Danbury for importation of a controlled

substance (MDMA). He has served two months of his sentence. He

now requests that the court release him to serve the remainder

of his sentence in home confinement due to the threat to his

health caused by the spread of COVID-19 in prisons. The threat

caused by COVID-19 to the health and safety of the public at

large is well-documented and constantly evolving.1 That threat

is even greater for incarcerated individuals due to the

constraints of the prison environment. As the Centers for

1 The court has issued numerous standing orders restricting access to the courthouse and postponing court proceedings due to the public health threat posed by the virus. See http://www.nhd.uscourts.gov/court-response-coronavirus-disease- covid-19.

4 Disease Control and Prevention (“CDC”) has recognized,

“[i]ncarcerated/detained persons live, work, eat, study, and

recreate within congregate environments, heightening the

potential for COVID-19 to spread once introduced.”2 Indeed,

defendant represents that 34 inmates and 12 staff members at FCI

Danbury have tested positive for the virus.

Defendant argues that he is eligible for compassionate

release because he has a higher risk of experiencing severe

illness from the virus due to his underlying health condition.

Defendant alleges that two years ago, his primary care physician

prescribed him an inhaler for his “breathing difficulties.”

Doc. no. 43 at 4. Defendant admits that his physician has not

diagnosed the source of these breathing issues but contends that

they worsen when he experiences increased anxiety. He also

submits that after being incarcerated in late February he made a

medical appointment and requested an inhaler but has not yet

been seen by prison medical staff. He also contends that, due

to the outbreak of COVID-19, his anxiety has “greatly

increased,” thereby exacerbating his breathing problems.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Willis
382 F. Supp. 3d 1185 (D. New Mexico, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
471 F. Supp. 3d 426, 2020 DNH 063, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-v-ahmad-khawaja-nhd-2020.